Tag: HIV drugs
-
Lenacapavir new antiretroviral drug for multi drug resistant HIV infection approved by USFDA
New anti-retroviral drug Lenacapavir approved by USFDA for treatment of multi drug resistant HIV 1 infection. On 22-Dec-2022 United States Food and Drug administration approved a new drug for treatment of HIV-1 infection, for patients where other drugs were developing drug resistance (Multi drug resistance). Name of Drug approved by the US FDA is Sunlenca which…
Guidelines on Pharmaceutical Manufacturing Pharma Quality Assurance Quality Management System 